Endoplasmic reticulum homeostasis: a potential target for diabetic nephropathy.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 09 03 2023
accepted: 31 05 2023
medline: 3 7 2023
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: epublish

Résumé

The endoplasmic reticulum (ER) is the most vigorous organelle in intracellular metabolism and is involved in physiological processes such as protein and lipid synthesis and calcium ion transport. Recently, the abnormal function of the ER has also been reported to be involved in the progression of kidney disease, especially in diabetic nephropathy (DN). Here, we reviewed the function of the ER and summarized the regulation of homeostasis through the UPR and ER-phagy. Then, we also reviewed the role of abnormal ER homeostasis in residential renal cells in DN. Finally, some ER stress activators and inhibitors were also summarized, and the possibility of maintaining ER homeostasis as a potential therapeutic target for DN was discussed.

Identifiants

pubmed: 37383398
doi: 10.3389/fendo.2023.1182848
pmc: PMC10296190
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1182848

Informations de copyright

Copyright © 2023 Yang, Liu, Jiang, Liu, Luo, Li, Zhao, Han, Chen, Li, Xiao and Sun.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Immunol Res. 2020 Apr 30;2020:6193407
pubmed: 32411800
Trends Biochem Sci. 2018 Aug;43(8):593-605
pubmed: 30056836
Front Cell Dev Biol. 2020 Nov 09;8:604240
pubmed: 33240899
Ageing Res Rev. 2017 Mar;34:3-14
pubmed: 27594375
PLoS One. 2015 Feb 25;10(2):e0117990
pubmed: 25714473
Metabolism. 2011 May;60(5):594-603
pubmed: 20817186
Physiol Rev. 2022 Jul 1;102(3):1393-1448
pubmed: 35188422
Cell. 2006 Feb 10;124(3):573-86
pubmed: 16469703
Naunyn Schmiedebergs Arch Pharmacol. 2016 Dec;389(12):1315-1324
pubmed: 27612855
J Antibiot (Tokyo). 2007 Sep;60(9):582-5
pubmed: 17917242
BMC Endocr Disord. 2021 Feb 23;21(1):28
pubmed: 33622304
Cell Death Dis. 2019 Oct 3;10(10):744
pubmed: 31582720
Cells. 2019 Nov 20;8(12):
pubmed: 31757001
Nat Rev Mol Cell Biol. 2002 Nov;3(11):836-47
pubmed: 12415301
Nature. 2021 Mar;591(7848):117-123
pubmed: 33442062
Toxicol Lett. 2017 Apr 5;271:26-37
pubmed: 28245985
Cell Death Dis. 2020 May 21;11(5):385
pubmed: 32439839
Front Pharmacol. 2016 Dec 21;7:500
pubmed: 28066247
Clin Exp Hypertens. 2012;34(4):243-8
pubmed: 22559034
J Hepatol. 2018 Oct;69(4):927-947
pubmed: 29940269
Ann Neurol. 2006 Mar;59(3):459-66
pubmed: 16429411
Front Physiol. 2019 May 15;10:561
pubmed: 31156453
Cancer. 2018 Aug;124(16):3307-3318
pubmed: 29671878
Cell Death Dis. 2012 May 03;3:e304
pubmed: 22552281
Phytomedicine. 2019 Mar 1;55:40-49
pubmed: 30668442
J Diabetes Res. 2017;2017:2615286
pubmed: 28791309
Clin Nutr. 2018 Oct;37(5):1474-1484
pubmed: 29249532
Cell. 2007 Dec 14;131(6):1047-58
pubmed: 18083096
J Cell Mol Med. 2020 Oct;24(19):11188-11197
pubmed: 32896039
J Clin Invest. 2011 Jun;121(6):2118-25
pubmed: 21633180
Lancet. 2012 Oct 20;380(9851):1387-95
pubmed: 22932717
Biomed Pharmacother. 2020 Nov;131:110655
pubmed: 32853909
Trends Cancer. 2016 May;2(5):252-262
pubmed: 28741511
J Vis Exp. 2013 May 07;(75):e50317
pubmed: 23685703
Biochem Biophys Res Commun. 2015 Aug 28;464(3):794-9
pubmed: 26187664
Cell Rep. 2022 Jan 11;38(2):110213
pubmed: 35021082
Redox Rep. 2022 Dec;27(1):32-44
pubmed: 35130817
Clin Exp Nephrol. 2020 Mar;24(3):205-215
pubmed: 31677062
Endocrinology. 2022 Jan 1;163(1):
pubmed: 34791124
Nat Commun. 2021 Jan 20;12(1):487
pubmed: 33473105
J Cell Biol. 2004 Feb 2;164(3):341-6
pubmed: 14757749
Autophagy. 2020 Jun;16(6):1164-1165
pubmed: 32267786
Biochem Soc Trans. 2012 Feb;40(1):279-81
pubmed: 22260705
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1627-1641
pubmed: 30946956
Methods Mol Biol. 2015;1292:205-14
pubmed: 25804758
Nat Commun. 2015 Jul 31;6:7841
pubmed: 26227493
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17019-24
pubmed: 19805154
Eur Rev Med Pharmacol Sci. 2017 Mar;21(5):1159-1168
pubmed: 28338173
Medicine (Baltimore). 2018 Jun;97(24):e11095
pubmed: 29901626
Cell Signal. 2021 Feb;78:109880
pubmed: 33307190
Clin Pharmacokinet. 2014 Jan;53(1):17-27
pubmed: 24105299
Annu Rev Cell Dev Biol. 2017 Oct 6;33:491-510
pubmed: 28793795
Sci Rep. 2019 Jul 8;9(1):9887
pubmed: 31285506
Expert Rev Endocrinol Metab. 2022 Jul;17(4):275-291
pubmed: 35822873
Trends Cell Biol. 2020 Jun;30(6):428-439
pubmed: 32413314
Front Cell Dev Biol. 2022 Feb 07;9:826248
pubmed: 35198567
Biol Trace Elem Res. 2020 Jul;196(1):10-19
pubmed: 31686395
Clin Cancer Res. 2019 Aug 15;25(16):4907-4916
pubmed: 31142508
Oxid Med Cell Longev. 2021 Aug 2;2021:7277966
pubmed: 34394833
Nutrients. 2016 Sep 22;8(10):
pubmed: 27669287
Nat Rev Microbiol. 2019 Nov;17(11):651-664
pubmed: 31485032
Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2563-2575
pubmed: 31199999
EBioMedicine. 2019 May;43:607-619
pubmed: 31060900
Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F409-15
pubmed: 26739891
FEBS J. 2022 Nov;289(22):7163-7176
pubmed: 34331743
Cell Calcium. 2018 Jan;69:62-72
pubmed: 28515000
Lipids Health Dis. 2018 Jul 31;17(1):183
pubmed: 30064425
Biomed Res Int. 2021 Jul 8;2021:1497449
pubmed: 34307650
Phytomedicine. 2022 Jan;95:153777
pubmed: 34815154
Eur J Neurosci. 2022 Jul;56(2):3806-3824
pubmed: 35543645
Drugs R D. 2011 Sep 1;11(3):227-49
pubmed: 21902286
Life Sci Alliance. 2019 May 17;2(3):
pubmed: 31101736
J Neurotrauma. 2022 Apr;39(7-8):560-576
pubmed: 35018820
EMBO J. 2008 Jan 23;27(2):315-27
pubmed: 18216874
J Biomed Sci. 2022 Jun 1;29(1):33
pubmed: 35650644
Arch Toxicol. 2022 Apr;96(4):1065-1074
pubmed: 35152301
Pathol Res Pract. 1980;167(2-4):204-16
pubmed: 7433232
Front Cell Dev Biol. 2021 Jul 09;9:684526
pubmed: 34307364
Cell Calcium. 2018 Jan;69:46-61
pubmed: 28747251
Cell Calcium. 2021 Mar;94:102343
pubmed: 33418313
Nature. 2000 Jan 27;403(6768):439-44
pubmed: 10667797
Eur J Pharm Sci. 2011 Apr 18;42(5):496-502
pubmed: 21345370
Diabetes Obes Metab. 2020 Apr;22 Suppl 1:3-15
pubmed: 32267079
Trends Biochem Sci. 2021 Aug;46(8):630-639
pubmed: 33509650
BMC Pulm Med. 2021 May 5;21(1):149
pubmed: 33952237
Curr Med Chem. 2021;28(14):2717-2728
pubmed: 33023427
Cell Physiol Biochem. 2014;33(6):1975-87
pubmed: 25012492
Biomolecules. 2021 Jan 28;11(2):
pubmed: 33525374
Am J Transl Res. 2020 Jun 15;12(6):2875-2889
pubmed: 32655816
Redox Biol. 2020 Sep;36:101635
pubmed: 32863214
Endocr Metab Immune Disord Drug Targets. 2022 Aug 15;22(7):787-794
pubmed: 34967303
J Diabetes Res. 2020 Jul 8;2020:7504798
pubmed: 32695831
J Cell Mol Med. 2021 Feb;25(3):1359-1370
pubmed: 33398919
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):
pubmed: 23251026
J Mol Cell Biol. 2017 Aug 1;9(4):274-288
pubmed: 28419336
Lab Invest. 2016 Jun;96(6):610-22
pubmed: 26999661
Aging (Albany NY). 2021 Jan 20;13(3):3405-3427
pubmed: 33495405
J Cell Physiol. 2019 Aug;234(10):18192-18205
pubmed: 30854676
J Renin Angiotensin Aldosterone Syst. 2013 Mar;14(1):3-13
pubmed: 22791702
Int J Mol Sci. 2020 Jul 28;21(15):
pubmed: 32731622
J Formos Med Assoc. 2018 Aug;117(8):662-675
pubmed: 29486908
Trends Plant Sci. 2018 Dec;23(12):1068-1080
pubmed: 30279071
Invest Ophthalmol Vis Sci. 2012 Jan 05;53(1):100-6
pubmed: 22110077
Plant Physiol Biochem. 2021 Sep;166:10-19
pubmed: 34087741
Am J Nephrol. 2008;28(6):1014-22
pubmed: 18648192
Gut. 2022 Dec;71(12):2561-2573
pubmed: 35365570
J Atheroscler Thromb. 2019 Mar 1;26(3):216-232
pubmed: 30726793
Cell Signal. 2022 Aug;96:110363
pubmed: 35644425
Biochem Biophys Res Commun. 2018 Oct 12;504(4):921-926
pubmed: 30224065
Muscle Nerve. 2007 Apr;35(4):430-42
pubmed: 17286271
J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):384-95
pubmed: 25031296
Annu Rev Pathol. 2015;10:173-94
pubmed: 25387057
Mol Cell Neurosci. 2015 May;66(Pt A):29-36
pubmed: 25724482
Cell Metab. 2006 Sep;4(3):245-54
pubmed: 16950141
Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F351-63
pubmed: 26672616
Pharmacol Res. 2020 Oct;160:105080
pubmed: 32673704
J Investig Med. 2016 Jan;64(1):2-6
pubmed: 26230493
Toxicology. 2020 May 15;437:152439
pubmed: 32197949
J Investig Med. 2013 Feb;61(2):256-64
pubmed: 23266706
Int J Mol Sci. 2022 Jan 24;23(3):
pubmed: 35163209
Am J Kidney Dis. 2018 Dec;72(6):798-810
pubmed: 30177485
J Clin Invest. 1996 Sep 15;98(6):1481-92
pubmed: 8823315
Mol Cell Endocrinol. 2015 Aug 15;411:232-42
pubmed: 25958041
Mol Aspects Med. 2018 Oct;63:18-29
pubmed: 29559224
Front Immunol. 2021 May 28;12:674316
pubmed: 34122432

Auteurs

Ming Yang (M)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Chongbin Liu (C)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Na Jiang (N)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Yan Liu (Y)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Shilu Luo (S)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Chenrui Li (C)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Hao Zhao (H)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Yachun Han (Y)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Wei Chen (W)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Li Li (L)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Li Xiao (L)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Lin Sun (L)

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH